Medtronic News - Business & regional news

Month Year

Email alerts

Oct 10, 2022

GI Genius™ named to FORTUNE 2022 ‘Change the World’ list

-- FORTUNE puts Medtronic among top 50 global companies having a positive social impact through core business strategy
- Gastrointestinal
Oct 5, 2022

Medtronic wins U.S. Department of Veterans Affairs contract to provide GI Genius™ intelligent endoscopy module for artificial intelligence (AI) assisted colon cancer screening

-- Veterans will have access to GI Genius™ intelligent endoscopy modules across the country that use AI help to detect colorectal polyps during colonoscopy --

-- Among Veterans, Colorectal cancer is of the five most frequently diagnosed cancers and a leading cause of cancer-related deaths --
- Americas
- Gastrointestinal
Sep 28, 2022

Medtronic Nexpowder™* Endoscopic Hemostasis System Receives U.S. FDA Clearance

-- Nexpowder™* provides gastroenterologists improved visibility, controls upper gastrointestinal (GI) bleeding effectively and with ease^1,2,3 --

-- Nexpowder™* endoscopic hemostasis system showed a lower rebleeding rate and has nearly double the adhesive force of other hemostatic sprays^2,3 --
- Gastrointestinal
Sep 21, 2022

Medtronic Ranked One of 2022 Best Workplaces in Asia™

Medtronic been ranked fifth in the 2022 Best Workplaces in Asia list by Great Place to Work, the global authority on workplace culture. This is a significant improvement of six places from 2021....
- Asia Pacific
Sep 21, 2022

Medtronic is the first and only company to receive FDA indication for bifurcation percutaneous coronary intervention with a drug-eluting stent

Bifurcation using Onyx Frontier DES Medtronic announced today that it has received Food and Drug Administration (FDA) approval for the treatment of non-left main bifurcation lesions utilizing the...
- Coronary and Renal Denervation
Sep 20, 2022

Medtronic receives CE mark for the first balloon expandable covered stent indicated for chimney endovascular aneurysm repair (ChEVAR)

Medtronic announced today that it recently received CE mark for its Radiant™ balloon-expandable covered stent, the first and currently only covered stent indicated for use in ChEVAR with the...
- Structural Heart and Aortic
Sep 18, 2022

MEDTRONIC UNVEILS NEW DATA FROM INVESTIGATIONAL INTREPID™ TRANSCATHETER MITRAL VALVE REPLACEMENT PROGRAM TO EXPAND TREATMENT OPTIONS FOR SEVERE MITRAL REGURGITATION

TCT 2022: Late-breaking data from Intrepid™ Pilot Study 3-year follow-up & 1-year follow-up from Transfemoral EFS study demonstrate promising valve performance Medtronic today announced new data...
- Structural Heart and Aortic
Sep 16, 2022

FIRST-EVER COMPARISON OF MICROCT AND HISTOLOGY IN SELF-EXPANDING TRANSCATHETER AORTIC VALVE REPLACEMENT PATIENTS WITH HYPO-ATTENUATED LEAFLET THICKENING

TCT 2022: Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets Medtronic today announced findings from its Pathological Study of Hypo-Attenuated...
- Structural Heart and Aortic
Sep 16, 2022

MEDTRONIC ANNOUNCES FULL MARKET LAUNCH IN U.S. OF EVOLUT™ FX NEXT-GEN TAVR SYSTEM FOR TREATMENT OF SYMPTOMATIC SEVERE AORTIC STENOSIS

TCT 2022: Medtronic Unveils Latest Transcatheter Aortic Valve Replacement Data in Late-Breaking Clinical Science and Presentations
- Structural Heart and Aortic
Sep 14, 2022

Medtronic Digital Surgery VP to Discuss Artificial Intelligence Applications in Healthcare at NVIDIA GTC

George Murgatroyd, general manager and vice president of Digital Surgery at Medtronic, will join Kimberly Powell, vice president of Healthcare and Life Sciences at NVIDIA, in a fireside chat at NVIDIA
- Surgical Robotics

Show per page